Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies.
Hellyer JA, Gubens MA, Cunanan KM, Padda SK, Burns M, Spittler AJ, Riess JW, San Pedro-Salcedo M, Ramchandran KJ, Neal JW, Wakelee HA, Loehrer PJ Sr.
Hellyer JA, et al. Among authors: loehrer pj sr.
Lung Cancer. 2019 Nov;137:71-75. doi: 10.1016/j.lungcan.2019.09.015. Epub 2019 Sep 18.
Lung Cancer. 2019.
PMID: 31557562
Clinical Trial.